Regulatory T cells coNTROL VEGF-dependent skin inflammation

Journal of Investigative Dermatology

Volumn 129, Issue 6, 2009, Pages 1437-1445

  Teige, Ingrid ^a   Hvid, Henning ^a   Svensson, Lars ^a   Kvist, Peter Helding ^a   Kemp, Kre ^a  

^a LEO PHARMA A S   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; SKIN INFLAMMATION; T LYMPHOCYTE ACTIVATION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; INFLAMMATION; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; SKIN; T-LYMPHOCYTES, REGULATORY; TETRADECANOYLPHORBOL ACETATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 67349114904     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.375     Document Type: Article

References (49)

1. Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910-4
2. Akiba H, Kehren J, Ducluzeau MT, Krasteva M, Horand F, Kaiserlian D et al. (2002) Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis. J Immunol 168:3079-87
3. Alford JG, Stanley PL, Todderud G, Tramposch KM (1992) Temporal infiltration of leukocyte subsets into mouse skin inflamed with phorbol ester. Agents Actions 37:260-7
4. Boehncke WH, Dressel D, Zollner TM, Kaufmann R (1996) Pulling the trigger on psoriasis. Nature 379:777
5. Bour H, Peyron E, Gaucherand M, Garrigue JL, Desvignes C, Kaiserlian D et al. (1995) Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Eur J Immunol 25:3006-10
6. Coombes JL, Robinson NJ, Maloy KJ, Uhlig HH, Powrie F (2005) Regulatory T cells and intestinal homeostasis. Immunol Rev 204:184-94
7. Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF et al. (1997) Hypoxia regulates the expression of vascular permeability factor/ vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. J Invest Dermatol 108:263-8
8. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200:277-285
9. Furtado GC, Olivares-Villagomez D, Curotto de Lafaille MA, Wensky AK, Latkowski JA, Lafaille JJ (2001) Regulatory T cells in spontaneous autoimmune encephalomyelitis. Immunol Rev 182:122-34
10. Ghoreschi K, Weigert C, Rocken M (2007) Immunopathogenesis and role of T cells in psoriasis. Clin Dermatol 25:574-80
11. Gocinski BL, Tigelaar RE (1990) Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 144:4121-8
12. Gorbachev AV, Fairchild RL (2001) Regulatory role of CD4+ T cells during the development of contact hypersensitivity responses. Immunol Res 24:69-77
13. Griffiths CE, Barker JN (2007) Pathogenesis and clinical features of psoriasis. Lancet 370:263-71
14. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1-8
15. Gutcher I, Becher B (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117:1119-27
16. Hartigan-O'Connor DJ, Poon C, Sinclair E, McCune JM (2007) Human CD4+ regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127), allowing consistent identification and sorting of live cells. J Immunol Methods 319:41-52
17. Hvid H, Teige I, Svensson L, Kvist PH, Kemp K (2008) TPA induction leads to a Th17 like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis. Int Immunol 20:1097-106
18. Kagen MH, McCormick TS, Cooper KD (2006) Regulatory T cells in psoriasis. Ernst Schering Res Found Workshop 56:193-209
19. Kelchtermans H, Geboes L, Mitera T, Huskens D, Leclercq G, Matthys P (2008) Activated CD4+CD25+ regulatory T cells inhibit osteoclastogen-esis and collagen-induced arthritis. Ann Rheum Dis E-pub ahead of print 14 May 2008.
20. Kish DD, Gorbachev AV, Fairchild RL (2007) Regulatory function of CD4+CD25+ T cells from Class II MHC-deficient mice in contact hypersensitivity responses. J Leukoc Biol 82:85-92
21. Kleyn CE, Griffiths CE (2006) Infliximab for the treatment of psoriasis. Expert Opin Biol Ther 6:797-805
22. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P et al. (2004) Induction of cutaneous delayed-type hypersensi-tivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104:1048-57
23. Lee E, Trepicchio WL, Oestreicher JL, Pittman D, Wang F, Chamian F et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-30
24. Lee YC (2005) The involvement of VEGF in endothelial permeability: a target for anti-inflammatory therapy. Curr Opin Investig Drugs 6:1124-30
25. Liu H, Hu B, Xu D, Liew FY (2003) CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4. J Immunol 171:5012-7
26. Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866-73
27. Morgan ME, Flierman R, van Duivenvoorde LM, Witteveen HJ, van Ewijk W, van Laar JM et al. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum 52:2212-21
28. Mueller W, Herrmann B (1979) Cyclosporin A for psoriasis. N Engl J Med 301:555
29. Nakamura K, Kitani A, Strober W (2001) Cell contact-dependent immuno-suppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 194:629-44
30. Nickoloff BJ, Wrone-Smith T (1999) Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol 155:145-58
31. Nickoloff BJ, Xin H, Nestle FO, Qin JZ (2007) The cytokine and chemokine network in psoriasis. Clin Dermatol 25:568-73
32. O'Connor RA, Anderton SM (2008) Foxp3+ regulatory T cells in the control of experimental CNS autoimmune disease. J Neuroimmunol 193:1-11
33. Rao TS, Currie JL, Shaffer AF, Isakson PC (1993) Comparative evaluation of arachidonic acid (AA)- and tetradecanoylphorbol acetate (TPA)-induced dermal inflammation. Inflammation 17:723-41
34. Ring S, Schafer SC, Mahnke K, Lehr HA, Enk AH (2006) CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur J Immunol 36:2981-92
35. Saint-Mezard P, Berard F, Dubois B, Kaiserlian D, Nicolas JF (2004) The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Eur J Dermatol 14:131-8
36. Saint-Mezard P, Krasteva M, Chavagnac C, Bosset S, Akiba H, Kehren J et al. (2003) Afferent and efferent phases of allergic contact dermatitis (ACD) can be induced after a single skin contact with haptens: evidence using a mouse model of primary ACD. J Invest Dermatol 120:641-7
37. Sakaguchi S, Sakaguchi N (2005) Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int Rev Immunol 24:211-26
38. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155:1151-64
39. Sakaguchi S, Setoguchi R, Yagi H, Nomura T (2006) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease. Curr Top Microbiol Immunol 305:51-66
40. Stanley PL, Steiner S, Havens M, Tramposch KM (1991) Mouse skin inflammation induced by multiple topical applications of 12-O- tetradecanoylphorbol-13-acetate. Skin Pharmacol 4:262-71
41. Sugiyama H, Gyulai R, Toichi E, Garaczi E, Shimada S, Stevens SR et al. (2005) Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J Immunol 174:164-73
42. Tobin AM, Kirby B (2005) TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis. BioDrugs 19:47-57
43. Walsh DA (2007) Pathophysiological mechanisms of angiogenesis. Adv Clin Chem 44:187-221
44. Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shahid S et al. (2000) CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 165:6783-90
45. Wang H, Peters T, Sindrilaru A, Kess D, Oreshkova T, Yu XZ et al. (2008) TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J Clin Invest 118: 2629-39
46. Wrone-Smith T, Nickoloff BJ (1996) Dermal injection of immunocytes induces psoriasis. J Clin Invest 98:1878-87
47. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102:161-8
48. Xu H, DiIulio NA, Fairchild RL (1996) T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med 183:1001-12
49. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S et al. (2004) IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16:249-56.